|
1
|
Kalpathy-Cramer J, Gerstner ER, Emblem KE,
Andronesi OC and Rosen B: Advanced magnetic resonance imaging of
the physical processes in human glioblastoma. Cancer Res.
74:4622–4637. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gloss BS and Dinger ME: The specificity of
long noncoding RNA expression. Biochim Biophys Acta. 1859:16–22.
2016. View Article : Google Scholar
|
|
3
|
Yoon JH, Kim J and Gorospe M: Long
noncoding RNA turnover. Biochimie. 117:15–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et
al: Functional demarcation of active and silent chromatin domains
in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li L, Liu B, Wapinski OL, Tsai MC, Qu K,
Zhang J, Carlson JC, Lin M, Fang F, Gupta RA, et al: Targeted
disruption of Hotair leads to homeotic transformation and gene
derepression. Cell Rep. 5:3–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alvarado DM, McCall K, Hecht JT, Dobbs MB
and Gurnett CA: Deletions of 5′ HOXC genes are associated with
lower extremity malformations, including clubfoot and vertical
talus. J Med Genet. 53:250–255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jing L, Yuan W, Ruofan D, Jinjin Y and
Haifeng Q: HOTAIR enhanced aggressive biological behaviors and
induced radio-resistance via inhibiting p21 in cervical cancer.
Tumour Biol. 36:3611–3619. 2015. View Article : Google Scholar
|
|
10
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015.
|
|
12
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spitale RC, Tsai MC and Chang HY: RNA
templating the epigenome: Long noncoding RNAs as molecular
scaffolds. Epigenetics. 6:539–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Ren Y, Zhang J, Zhang C, Zhang K,
Han L, Kong L, Wei J, Chen L, Yang J, et al: HOTAIR is a
therapeutic target in glioblastoma. Oncotarget. 6:8353–8365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al Chinese Glioma
Cooperative Group: HOTAIR, a cell cycle-associated long noncoding
RNA and a strong predictor of survival, is preferentially expressed
in classical and mesenchymal glioma. Neuro Oncol. 15:1595–1603.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McInerny CJ: Cell cycle regulated
transcription: From yeast to cancer. F1000Res. 5:52016. View Article : Google Scholar
|
|
17
|
Visconti R, Della Monica R and Grieco D:
Cell cycle checkpoint in cancer: A therapeutically targetable
double-edged sword. J Exp Clin Cancer Res. 35:1532016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bucher N and Britten CD: G2 checkpoint
abrogation and checkpoint kinase-1 targeting in the treatment of
cancer. Br J Cancer. 98:523–528. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15 (INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar
|
|
21
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, et al:
Long noncoding RNA MALAT1 controls cell cycle progression by
regulating the expression of oncogenic transcription factor B-MYB.
PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Kwok CT, Leung MH, Qin J, Qin Y, Wang J,
Lee YL and Yao KM: The Forkhead box transcription factor FOXM1 is
required for the maintenance of cell proliferation and protection
against oxidative stress in human embryonic stem cells. Stem Cell
Res (Amst). 16:651–661. 2016. View Article : Google Scholar
|
|
24
|
Barger CJ, Zhang W, Hillman J, Stablewski
AB, Higgins MJ, Vanderhyden BC, Odunsi K and Karpf AR: Genetic
determinants of FOXM1 overexpression in epithelial ovarian cancer
and functional contribution to cell cycle progression. Oncotarget.
6:27613–27627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu ZY, Ma XS, Qi ST, Wang ZB, Guo L,
Schatten H, Sun QY and Sun YP: Cep55 regulates spindle organization
and cell cycle progression in meiotic oocyte. Sci Rep. 5:169782015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Q, Han L, Dong Y, Tian J, Huang W,
Liu Z, Jia X, Jiang T, Zhang J, Li X, et al: JAK2/STAT3 targeted
therapy suppresses tumor invasion via disruption of the
EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in
EGFRvIII-expressing glioblastoma. Neuro Oncol. 16:1229–1243. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Loukil A, Cheung CT, Bendris N, Lemmers B,
Peter M and Blanchard JM: Cyclin A2: At the crossroads of cell
cycle and cell invasion. World J Biol Chem. 6:346–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gong D and Ferrell JE Jr: The roles of
cyclin A2, B1, and B2 in early and late mitotic events. Mol Biol
Cell. 21:3149–3161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carrassa L and Damia G: Unleashing Chk1 in
cancer therapy. Cell Cycle. 10:2121–2128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cabello OA, Eliseeva E, He WG, Youssoufian
H, Plon SE, Brinkley BR and Belmont JW: Cell cycle-dependent
expression and nucleolar localization of hCAP-H. Mol Biol Cell.
12:3527–3537. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vitre B, Gudimchuk N, Borda R, Kim Y,
Heuser JE, Cleveland DW and Grishchuk EL: Kinetochore-microtubule
attachment throughout mitosis potentiated by the elongated stalk of
the kinetochore kinesin CENP-E. Mol Biol Cell. 25:2272–2281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mazumdar M, Sundareshan S and Misteli T:
Human chromo-kinesin KIF4A functions in chromosome condensation and
segregation. J Cell Biol. 166:613–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chou HY, Wang TH, Lee SC, Hsu PH, Tsai MD,
Chang CL and Jeng YM: Phosphorylation of NuSAP by Cdk1 regulates
its interaction with microtubules in mitosis. Cell Cycle.
10:4083–4089. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Higgins J, Midgley C, Bergh AM, Bell SM,
Askham JM, Roberts E, Binns RK, Sharif SM, Bennett C, Glover DM, et
al: Human ASPM participates in spindle organisation, spindle
orientation and cytokinesis. BMC Cell Biol. 11:852010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goldenson B and Crispino JD: The aurora
kinases in cell cycle and leukemia. Oncogene. 34:537–545. 2015.
View Article : Google Scholar
|
|
36
|
Nunes Bastos R, Gandhi SR, Baron RD,
Gruneberg U, Nigg EA and Barr FA: Aurora B suppresses microtubule
dynamics and limits central spindle size by locally activating
KIF4A. J Cell Biol. 202:605–621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wierstra I: The transcription factor FOXM1
(Forkhead box M1): Proliferation-specific expression, transcription
factor function, target genes, mouse models, and normal biological
roles. Adv Cancer Res. 118:97–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tilghman J, Wu H, Sang Y, Shi X,
Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J and
Ying M: HMMR maintains the stemness and tumorigenicity of
glioblastoma stem-like cells. Cancer Res. 74:3168–3179. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Horvath S, Zhang B, Carlson M, Lu KV, Zhu
S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, et al: Analysis
of oncogenic signaling networks in glioblastoma identifies ASPM as
a molecular target. Proc Natl Acad Sci USA. 103:17402–17407. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stangeland B, Mughal AA, Grieg Z, Sandberg
CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO and Langmoen
IA: Combined expressional analysis, bioinformatics and targeted
proteomics identify new potential therapeutic targets in
glioblastoma stem cells. Oncotarget. 6:26192–26215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang ML, Hsieh TH, Ng KH, Tsai YN, Tsai
CF, Chao ME, Liu DJ, Chu SS, Chen W, Liu YR, et al: Downregulation
of miR-137 and miR-6500-3p promotes cell proliferation in pediatric
high-grade gliomas. Oncotarget. 7:19723–19737. 2016.PubMed/NCBI
|
|
43
|
Tang Y, Dai Y, Grant S and Dent P:
Enhancing CHK1 inhibitor lethality in glioblastoma. Cancer Biol
Ther. 13:379–388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun
J, Han K, Shen J, Zhu M, Lin Z, et al: Centrosomal Protein of 55
regulates glucose metabolism, proliferation and apoptosis of glioma
cells via the Akt/mTOR signaling pathway. J Cancer. 7:1431–1440.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Valente V, Serafim RB, de Oliveira LC,
Adorni FS, Torrieri R, Tirapelli DP, Espreafico EM, Oba-Shinjo SM,
Marie SK, Paçó-Larson ML, et al: Modulation of HJURP (Holliday
Junction-Recognizing Protein) levels is correlated with
glioblastoma cells survival. PLoS One. 8:e622002013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Diaz RJ, Golbourn B, Shekarforoush M,
Smith CA and Rutka JT: Aurora kinase B/C inhibition impairs
malignant glioma growth in vivo. J Neurooncol. 108:349–360. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takashima S, Saito H, Takahashi N, Imai K,
Kudo S, Atari M, Saito Y, Motoyama S and Minamiya Y: Strong
expression of cyclin B2 mRNA correlates with a poor prognosis in
patients with non-small cell lung cancer. Tumour Biol.
35:4257–4265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shubbar E, Kovács A, Hajizadeh S, Parris
TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P and Helou K:
Elevated cyclin B2 expression in invasive breast carcinoma is
associated with unfavorable clinical outcome. BMC Cancer. 13:12013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim DH, Park SE, Kim M, Ji YI, Kang MY,
Jung EH, Ko E, Kim Y, Kim S, Shim YM, et al: A functional single
nucleotide polymorphism at the promoter region of cyclin A2 is
associated with increased risk of colon, liver, and lung cancers.
Cancer. 117:4080–4091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Moore NL, Edwards DP and Weigel NL: Cyclin
A2 and its associated kinase activity are required for optimal
induction of progesterone receptor target genes in breast cancer
cells. J Steroid Biochem Mol Biol. 144:471–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13(22 Pt 1): 6624–6631.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang H, Lu C, Li Q, Xie J, Chen T, Tan Y,
Wu C and Jiang J: The role of Kif4A in doxorubicin-induced
apoptosis in breast cancer cells. Mol Cells. 37:812–818. 2014.
View Article : Google Scholar : PubMed/NCBI
|
